Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Peter Nash, Iain B McInnes, Philip J Mease, Howard Thom, Matthias Hunger, Andreas Karabis, Kunal Gandhi, Shephard Mpofu, Steffen M Jugl

Research output: Contribution to journal › Comment/debate (Academic Journal) › peer-review

241 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science